WPW
BMY icon

Winthrop Partners - WNY’s Bristol-Myers Squibb BMY Stock Holding History

Winthrop Partners - WNY’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$94.6K Sell
1,866
-90
-5% -$4.23K 0.06% 149
2019
Q2 		$88.7K Buy
1,956
+1,206
+161% +$56.2K 0.07% 129
2019
Q1 		$35.3K Sell
750
-428
-36% -$21.3K 0.03% 162
2018
Q4 		$61.2K Hold
1,178
– – 0.06% 138
2018
Q3 		$73.1K Sell
1,178
-72
-6% -$4.27K 0.06% 157
2018
Q2 		$69.2K Hold
1,250
– – 0.06% 165
2018
Q1 		$75.6K Buy
+1,250
New +$80.4K 0.06% 185

Other funds holding BMY

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Winthrop Partners - WNY's BMY Position: Q3 2019 in Review

Winthrop Partners - WNY reduced its Bristol-Myers Squibb (BMY) stake by 4.6% in Q3 2019, selling an estimated $4.23K and leaving 1,866 shares worth $94.6K. The position accounts for 0.06% of the portfolio, ranked #149.

Winthrop Partners - WNY first reported a position in BMY in Q1 2018 and has held it in 7 quarters since. 1,813 funds tracked by Wall St. Rank hold BMY as of Q3 2019.

  • Winthrop Partners - WNY held 1,866 shares of Bristol-Myers Squibb worth $94.6K as of Q3 2019.
  • Winthrop Partners - WNY sold 90 Bristol-Myers Squibb shares in Q3 2019, an estimated $4.23K.
  • Bristol-Myers Squibb made up 0.06% of Winthrop Partners - WNY's portfolio in Q3 2019, its #149 holding.
  • Winthrop Partners - WNY first reported a position in Bristol-Myers Squibb in Q1 2018 and has held it in 7 quarters since.
  • 1,813 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2019.

Based on Winthrop Partners - WNY's 13F filing for Q3 2019, filed 28 Oct 2019.